New resource on how to help prevent an opioid related death. Learn about an overdose including the symptoms, how to respond, information on naloxone, tips on preventing an overdose, and resources for seeking help. Download and share now.
What is Naloxone?
Naloxone is a medication designed to rapidly reverse opioid overdose. It is an opioid antagonist—meaning that it binds to opioid receptors and can reverse and block the effects of other opioids. It can very quickly restore normal respiration to a person whose breathing has slowed or stopped as a result of overdosing with heroin or prescription opioid pain medications.
Association of Opioids Prescribed to Family Members With Opioid Overdose Among Adolescents and Young Adults
Importance: Family members are cited as a common source of prescription opioids used for nonmedical reasons. However, the overdose risk associated with exposure to opioids prescribed to family members among adolescents and young adults is not well established.
Often it takes a critical moment, such as when someone survives an overdose, to motivate behavioural change.
It is particularly important that at these times people have access to the appropriate treatment.
Turning Point will be offering a free webinar Tuesday 3rd March 2020 at 8:30 AM ACST
This session aims to briefly cover the main opioid agonist pharmacotherapies for opioid dependence, and summarise the evidence for the use of these treatments for pharmaceutical opioid dependence.
Medication can enhance recovery and prevent overdose when it is coupled with other behavioural health interventions that focus on substance use disorders and addiction.
Join the Center of Excellence for Integrated Health Solutions to discover what medication-assisted treatment is, identify when to implement it, and how to successfully integrate it into recovery care plans.
July 2nd, 2 pm Eastern Time (ET)
Opioid overdose is a significant public health issue, with people who inject drugs (PWID) a key risk group. However, there is little contemporary information on opioid overdose incidence in Australia and limited evidence of the impact of factors affecting incidence among PWID. Further evidence on the risk and protective factors of an opioid overdose will help determine how to prevent these overdoses from occurring.
Question: Is 800 μg of naloxone hydrochloride administered intranasally as effective in reversing opioid overdose as the same dose administered intramuscularly?